Kishore Kumar Jella1, Tahseen H Nasti2, Zhentian Li1, David H Lawson3, Jeffrey M Switchenko4, Rafi Ahmed2, William S Dynan5, Mohammad K Khan6. 1. Department of Radiation Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, Georgia. 2. Department of Microbiology and Immunology, School of Medicine, Emory University, Atlanta, Georgia. 3. Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, Georgia. 4. Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia. 5. Department of Radiation Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, Georgia; Department of Biochemistry, School of Medicine, Emory University, Atlanta, Georgia. 6. Department of Radiation Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, Georgia. Electronic address: drkhurram2000@gmail.com.
Abstract
PURPOSE: To investigate the ability of radiation to stimulate exosome release from melanoma cells and to characterize the resulting exosome-containing vesicle preparations for their ability to promote a host antitumor immune response. MATERIALS AND METHODS: Cultured B16F10 murine melanoma cells or tumors were irradiated, and secreted extracellular vesicles were isolated and characterized. The exosome-containing vesicle preparations were injected into fresh tumors in syngeneic mice, and tumor growth and infiltrating T cells and natural killer (NK) cells were characterized. RESULTS: Irradiation stimulated exosome release from B16F10 murine melanoma cells. Exosome preparations from irradiated cell culture supernatants were biologically active, as demonstrated by uptake into recipient cells and by the ability to induce dendritic cell maturation and activation in vitro. Intratumoral injection significantly delayed tumor growth in vivo, whereas injection of similar preparations from non irradiated cells had no effect. The antitumor effect was correlated to an increase in interferon gamma-producing tumor-infiltrating NK cells. Pretreatment of the host mice with anti-NK cell antibodies abolished the effect, whereas pretreatment with anti-CD8+ T-cell antibodies did not. CONCLUSION: Exosomes from irradiated cells, or synthetic mimics, might provide an effective strategy for potentiation of NK cell-mediated host antitumor immunity.
PURPOSE: To investigate the ability of radiation to stimulate exosome release from melanoma cells and to characterize the resulting exosome-containing vesicle preparations for their ability to promote a host antitumor immune response. MATERIALS AND METHODS: Cultured B16F10murinemelanoma cells or tumors were irradiated, and secreted extracellular vesicles were isolated and characterized. The exosome-containing vesicle preparations were injected into fresh tumors in syngeneic mice, and tumor growth and infiltrating T cells and natural killer (NK) cells were characterized. RESULTS: Irradiation stimulated exosome release from B16F10murinemelanoma cells. Exosome preparations from irradiated cell culture supernatants were biologically active, as demonstrated by uptake into recipient cells and by the ability to induce dendritic cell maturation and activation in vitro. Intratumoral injection significantly delayed tumor growth in vivo, whereas injection of similar preparations from non irradiated cells had no effect. The antitumor effect was correlated to an increase in interferon gamma-producing tumor-infiltrating NK cells. Pretreatment of the host mice with anti-NK cell antibodies abolished the effect, whereas pretreatment with anti-CD8+ T-cell antibodies did not. CONCLUSION: Exosomes from irradiated cells, or synthetic mimics, might provide an effective strategy for potentiation of NK cell-mediated host antitumor immunity.
Authors: Byron C Burnette; Hua Liang; Youjin Lee; Lukasz Chlewicki; Nikolai N Khodarev; Ralph R Weichselbaum; Yang-Xin Fu; Sogyong L Auh Journal: Cancer Res Date: 2011-02-07 Impact factor: 12.701
Authors: Ammar Al-Mayah; Scott Bright; Kim Chapman; Sarah Irons; Ping Luo; David Carter; Edwin Goodwin; Munira Kadhim Journal: Mutat Res Date: 2014-12-30 Impact factor: 2.433
Authors: W Tris Arscott; Anita T Tandle; Shuping Zhao; Jacob E Shabason; Ira K Gordon; Cody D Schlaff; Guofeng Zhang; Philip J Tofilon; Kevin A Camphausen Journal: Transl Oncol Date: 2013-12-01 Impact factor: 4.243
Authors: Brian D Lehmann; Matthew S Paine; Adam M Brooks; James A McCubrey; Randall H Renegar; Rong Wang; David M Terrian Journal: Cancer Res Date: 2008-10-01 Impact factor: 12.701
Authors: Quan Lu; Lila Weiqiao Hope; Michael Brasch; Christoph Reinhard; Stanley N Cohen Journal: Proc Natl Acad Sci U S A Date: 2003-06-11 Impact factor: 11.205